Danny Yeung Keynote Speaker

CEO of Prenetics, one of the world's leading Covid-19 testing providers
Former CEO of Groupon East Asia
Serial entrepreneur in diagnostic health and hospitality

Danny Yeung's Biography

Danny Yeung is the CEO and Co-Founding Partner of IM8 Health, the premium wellness and longevity company co-founded alongside global icon David Beckham. Prenetics is a leading genetics and diagnostic health testing company whose rapid Covid-19 testing technology became a major testing provider during the pandemic. With over 5 million tests performed to date, the company has provided regular testing for English Premier League players, as well as travelers and staff at London Heathrow and Hong Kong International airports. Prenetics also announced a public listing deal valuing the company at USD $1.25 billion.

Prior to Prenetics, Danny led multiple investments in DNA Genetic testing companies as Founding Partner/Investor at SXE Ventures. Previously, Danny founded uBuyiBuy in 2010, which was subsequently acquired by Groupon. Prior to Danny leaving Groupon in early 2014, Danny served as CEO of Groupon East Asia, having scaled the business to a size of over USD $130m annually, overseeing a staff of 350 and becoming highly profitable.

Danny’s entrepreneurial journey started at the age of 25 when he ventured into franchising Hong Kong’s award-winning dessert chain Hui Lau Shan into USA. After exiting Hui Lau Shan, Danny successfully ventured into hospitality furniture and executed multi-million dollar projects with MGM City Center, City of Dreams Macau and Venetian. Danny is currently a Founding Partner at SXE Ventures, Board Member at Parabase Genomics, Limited Partner and Mentor for 500 Startups.

Danny received his BS in MIS from the University of San Francisco.

Entrepreneurship, scaling startups and business growth

The future of digital health and preventative healthcare

Longevity, wellness and human performance optimisation

Innovation in genetics, diagnostics and biotech

Leadership lessons from hyper-growth and global expansion

He operates at the forefront of health technology and longevity, building companies that combine diagnostics, genetics and performance optimisation.
He translates advances in health innovation into scalable solutions that improve wellbeing, preventative care and human performance.
He brings exceptional entrepreneurial experience, having founded and scaled multiple high-growth businesses across health, technology and consumer sectors.
He is an engaging speaker who shares practical insights on innovation, resilience and building globally disruptive companies.
His insights equip organisations to understand the future of healthcare, embrace emerging technologies and drive long-term growth through innovation.